Larry W Kwak

Larry W Kwak

UNVERIFIED PROFILE

Are you Larry W Kwak?   Register this Author

Register author
Larry W Kwak

Larry W Kwak

Publications by authors named "Larry W Kwak"

Are you Larry W Kwak?   Register this Author

100Publications

2721Reads

25Profile Views

CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignancies.

Sci Transl Med 2019 Sep;11(511)

Toni Stephenson Lymphoma Center, Department of Hematology and Hematopoietic Cell Transplantation, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scitranslmed.aaw9414DOI Listing
September 2019

Targeting myeloid-derived suppressor cells for cancer immunotherapy.

Cancer Immunol Immunother 2018 Aug 31;67(8):1181-1195. Epub 2018 May 31.

Toni Stephenson Lymphoma Center, Department of Hematology and Hematopoietic Stem Cell Transplantation, Beckman Research Institute of City of Hope, 1500 East Duarte Road, Duarte, CA, 91010, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00262-018-2175-3
Publisher Site
http://dx.doi.org/10.1007/s00262-018-2175-3DOI Listing
August 2018

Novel BAFF-Receptor Antibody to Natively Folded Recombinant Protein Eliminates Drug-Resistant Human B-cell Malignancies .

Clin Cancer Res 2018 03 27;24(5):1114-1123. Epub 2017 Nov 27.

Beckman Research Institute City of Hope National Medical Center, Toni Stephenson Lymphoma Center, and Department of Hematology and Hematopoietic Stem Cell Transplantation, Duarte, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-1193DOI Listing
March 2018

Phase I study of an active immunotherapy for asymptomatic phase Lymphoplasmacytic lymphoma with DNA vaccines encoding antigen-chemokine fusion: study protocol.

BMC Cancer 2018 02 13;18(1):187. Epub 2018 Feb 13.

Toni Stephenson Lymphoma Center, Department of Hematology and Hematopoietic Stem Cell Transplantation, Beckman Research Institute of City of Hope, Duarte, CA, 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-018-4094-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812202PMC
February 2018

Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation.

J Clin Oncol 2017 Jan 24;35(1):24-31. Epub 2016 Oct 24.

Alex F. Herrera, Matthew Mei, Lawrence Low, Joo Y. Song, Victoria Bedell, Lithua Budde, Wing C. Chan, Robert Chen, Joyce Murata-Collins, Auayporn P. Nademanee, Raju Pillai, Leslie Popplewell, Tanya Siddiqi, Jasmine Zain, Steven T. Rosen, Larry W. Kwak, Stephen J. Forman, Dennis D. Weisenburger, Young Kim, Amrita Krishnan, Tanya Paris, Tracey Stiller, Joycelynne M. Palmer, City of Hope National Medical Center, Duarte, CA; Haesook T. Kim, Jennifer R. Brown, Matthew S. Davids, Arnold S. Freedman, David C. Fisher, Eric D. Jacobsen, Caron A. Jacobson, Ann S. LaCasce, David M. Weinstock, Scott J. Rodig, Philippe Armand, Dana-Farber Cancer Institute; Gabriel K. Griffin, Reid W. Merryman, Christine Pak, Heather Sun, Brigham and Women's Hospital; German A. Pihan, Beth Israel Deaconess Medical Center; and Aliyah R. Sohani, Massachusetts General Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.2740DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455688PMC
January 2017

IL-15 enhances the antitumor effect of human antigen-specific CD8 T cells by cellular senescence delay.

Oncoimmunology 2016 7;5(12):e1237327. Epub 2016 Oct 7.

Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center , Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2016.1237327DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215241PMC
October 2016

Targeting B-cell malignancies through human B-cell receptor specific CD4 T cells.

Oncoimmunology 2016 19;5(11):e1232220. Epub 2016 Sep 19.

Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center , Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2016.1232220DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5139634PMC
September 2016

Phase II study of an AKT inhibitor MK2206 in patients with relapsed or refractory lymphoma.

Br J Haematol 2015 Nov 27;171(4):463-70. Epub 2015 Jul 27.

Department of Lymphoma/Myeloma, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13603DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278973PMC
November 2015

Mature adipocytes in bone marrow protect myeloma cells against chemotherapy through autophagy activation.

Oncotarget 2015 Oct;6(33):34329-41

Department of Lymphoma and Myeloma, Division of Cancer Medicine, Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.6020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741456PMC
October 2015

Anti-β₂-microglobulin monoclonal antibodies overcome bortezomib resistance in multiple myeloma by inhibiting autophagy.

Oncotarget 2015 Apr;6(11):8567-78

Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496167PMC
http://dx.doi.org/10.18632/oncotarget.3251DOI Listing
April 2015

Towards an off-the-shelf vaccine therapy targeting shared B-cell tumor idiotypes.

Am J Blood Res 2014 15;4(2):46-52. Epub 2014 Dec 15.

Department of Lymphoma and Myeloma, M.D. Anderson Cancer Center Houston, TX, USA ; Center for Cancer Immunology Research, M.D. Anderson Cancer Center Houston, TX, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348793PMC
March 2015

Targeting tumor-associated myeloid cells for cancer immunotherapy.

Oncoimmunology 2015 Mar 2;4(3):e983961. Epub 2015 Apr 2.

Department of Lymphoma and Myeloma; The University of Texas MD Anderson Cancer Center ; Houston, TX, USA ; Center for Cancer Immunology Research; The University of Texas MD Anderson Cancer Center ; Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/2162402X.2014.983761DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404802PMC
March 2015

Selective targeting of Toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphoma.

Int J Cancer 2014 Dec 12;135(12):2834-46. Epub 2014 May 12.

Department of Immunology, The University of Texas M.D. Anderson Cancer Center, Houston, TX; Center for Cancer Immunology Research, The University of Texas M.D. Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ijc.28937
Publisher Site
http://dx.doi.org/10.1002/ijc.28937DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352105PMC
December 2014

Rush hour traffic: directing T cells to tumor.

J Natl Cancer Inst 2014 Nov 24;106(11). Epub 2014 Sep 24.

Department of Lymphoma and Myeloma and Center for Cancer Immunology Research, University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
https://academic.oup.com/jnci/article-lookup/doi/10.1093/jnc
Publisher Site
http://dx.doi.org/10.1093/jnci/dju301DOI Listing
November 2014

Bone marrow stromal cells derived MCP-1 reverses the inhibitory effects of multiple myeloma cells on osteoclastogenesis by upregulating the RANK expression.

PLoS One 2013 10;8(12):e82453. Epub 2013 Dec 10.

Department of Lymphoma and Myeloma, Division of Cancer Medicine, Center for Cancer Immunology Research, The University of Texas M D Anderson Cancer Center, Houston, Texas, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0082453PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3858321PMC
September 2014

The effect of combined IL10 siRNA and CpG ODN as pathogen-mimicking microparticles on Th1/Th2 cytokine balance in dendritic cells and protective immunity against B cell lymphoma.

Biomaterials 2014 Jul 8;35(21):5491-504. Epub 2014 Apr 8.

The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA 30332, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biomaterials.2014.03.039DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747034PMC
July 2014

Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice.

Nat Med 2014 Jun 25;20(6):676-81. Epub 2014 May 25.

1] Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. [2] Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. [3] The University of Texas Graduate School of Biomedical Sciences, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm.3560DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4048321PMC
June 2014

Phase I study of panobinostat plus everolimus in patients with relapsed or refractory lymphoma.

Clin Cancer Res 2013 Dec 4;19(24):6882-90. Epub 2013 Oct 4.

Authors' Affiliations: Departments of Lymphoma/Myeloma, Diagnostic Imaging, and Biostatistics, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-1906DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409814PMC
December 2013

In vitro and in vivo therapeutic efficacy of carfilzomib in mantle cell lymphoma: targeting the immunoproteasome.

Mol Cancer Ther 2013 Nov 29;12(11):2494-504. Epub 2013 Aug 29.

Corresponding Authors: Liang Zhang, Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 0903, Houston, TX 77030.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-13-0156DOI Listing
November 2013

Antibodies targeting human OX40 expand effector T cells and block inducible and natural regulatory T cell function.

J Immunol 2013 Oct 6;191(7):3641-50. Epub 2013 Sep 6.

Department of Immunology, Center for Cancer Immunology Research, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1202752DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3812678PMC
October 2013

Immune evasion of mantle cell lymphoma: expression of B7-H1 leads to inhibited T-cell response to and killing of tumor cells.

Haematologica 2013 Sep 18;98(9):1458-66. Epub 2013 Mar 18.

Bone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2012.071340DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762104PMC
September 2013

p38 MAPK in myeloma cells regulates osteoclast and osteoblast activity and induces bone destruction.

Cancer Res 2012 Dec 11;72(24):6393-402. Epub 2012 Oct 11.

Department of Lymphoma/Myeloma, Division of Cancer Medicine and Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-12-2664DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525770PMC
December 2012

Role of the microenvironment in mantle cell lymphoma: IL-6 is an important survival factor for the tumor cells.

Blood 2012 Nov 11;120(18):3783-92. Epub 2012 Sep 11.

Department of Lymphoma/Myeloma, Division of Cancer Medicine, Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2012-04-42
Publisher Site
http://dx.doi.org/10.1182/blood-2012-04-424630DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488890PMC
November 2012

TCL1: a shared tumor-associated antigen for immunotherapy against B-cell lymphomas.

Blood 2012 Aug 29;120(8):1613-23. Epub 2012 May 29.

Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2011-09-382838DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429305PMC
August 2012

Novel phosphatidylinositol 3-kinase inhibitor NVP-BKM120 induces apoptosis in myeloma cells and shows synergistic anti-myeloma activity with dexamethasone.

J Mol Med (Berl) 2012 Jun 30;90(6):695-706. Epub 2011 Dec 30.

Department of Lymphoma/Myeloma, Division of Cancer Medicine, Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00109-011-0849-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212830PMC
June 2012

Lymphoma vaccine therapy: next steps after a positive, controlled phase III clinical trial.

Semin Oncol 2012 Jun;39(3):253-62

Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2012.02.014DOI Listing
June 2012

Calcium blockers decrease the bortezomib resistance in mantle cell lymphoma via manipulation of tissue transglutaminase activities.

Blood 2012 Mar 31;119(11):2568-78. Epub 2012 Jan 31.

Centre for Stem Cell Research, Brown Foundation Institute of Molecular Medicine for Prevention of Human Diseases, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2011-09-377598DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3311276PMC
March 2012

T cells and T cell tumors efficiently generate antigen-specific cytotoxic T cell immunity when modified with an NKT ligand.

Oncoimmunology 2012 Mar;1(2):141-151

Department of Immunology; Center for Cancer Immunology Research; University of Texas MD Anderson Cancer Center; Houston, TX USA ; Institute of Molecular Medicine; University of Texas Medical School; Houston, TX USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/onci.1.2.18479DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376985PMC
March 2012

Bortezomib-resistant nuclear factor κB expression in stem-like cells in mantle cell lymphoma.

Exp Hematol 2012 Feb 21;40(2):107-18.e2. Epub 2011 Oct 21.

Centre for Stem Cell Research, Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, University of Texas-Health Science Center at Houston, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2011.10.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398482PMC
February 2012

An injectable synthetic immune-priming center mediates efficient T-cell class switching and T-helper 1 response against B cell lymphoma.

J Control Release 2011 Oct 21;155(2):184-92. Epub 2011 Jun 21.

Department of Biomedical Engineering, The University of Texas, Austin, TX 78712, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01683659110039
Publisher Site
http://dx.doi.org/10.1016/j.jconrel.2011.06.008DOI Listing
October 2011

Targeting human B-cell malignancies through Ig light chain-specific cytotoxic T lymphocytes.

Clin Cancer Res 2011 Sep 3;17(18):5945-52. Epub 2011 Aug 3.

Department of Lymphoma and Myeloma, Stem Cell Transplantation and Cellular Therapy, and Center for Cancer Immunology Research, MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-0970DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3176952PMC
September 2011

Targeting cell surface β2 -microglobulin by pentameric IgM antibodies.

Br J Haematol 2011 Jul 9;154(1):111-21. Epub 2011 May 9.

Department of Lymphoma/Myeloma, Division of Cancer Medicine, Center for Cancer Immunology Research, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2011.08714.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3111817PMC
July 2011

Cancer vaccines: moving toward prevention?

Authors:
Larry W Kwak

Cancer Prev Res (Phila) 2011 Jul;4(7):954-6

Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 429, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-11-0236DOI Listing
July 2011

Identification of human idiotype-specific T cells in lymphoma and myeloma.

Curr Top Microbiol Immunol 2011 ;344:193-210

Department of Lymphoma and Myeloma, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/82_2010_70
Publisher Site
http://dx.doi.org/10.1007/82_2010_70DOI Listing
June 2011

Translational development of vaccination strategies in follicular NHL.

Best Pract Res Clin Haematol 2011 Jun 6;24(2):295-304. Epub 2011 May 6.

Department of Lymphoma/Myeloma and Center for Cancer Immunology Research, Unit 0903, MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2011.03.007DOI Listing
June 2011

Prospective isolation of clonogenic mantle cell lymphoma-initiating cells.

Stem Cell Res 2010 Nov 6;5(3):212-25. Epub 2010 Aug 6.

Centre for Stem Cell Research, Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (IMM), The University of Texas-Health Science Center at Houston, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.scr.2010.07.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2952723PMC
November 2010

Generation of an immune microenvironment as a novel mechanism for myotoxins to potentiate genetic vaccines.

Vaccine 2010 Nov;28(50):7970-8

Department of Lymphoma, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2010.09.084DOI Listing
November 2010

Effect of long-term storage in TRIzol on microarray-based gene expression profiling.

Cancer Epidemiol Biomarkers Prev 2010 Oct 30;19(10):2445-52. Epub 2010 Aug 30.

The Myeloma Tissue and Leukemia Satellite Sample Banks, Department of Lymphoma and Myeloma, University of Texas M D Anderson Cancer Center, Houston, Texas 77054, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-10-0565DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2966770PMC
October 2010

Prime-boost vaccination using chemokine-fused gp120 DNA and HIV envelope peptides activates both immediate and long-term memory cellular responses in rhesus macaques.

J Biomed Biotechnol 2010 5;2010:860160. Epub 2010 May 5.

Department of Lymphoma and Myeloma, M. D. Anderson Cancer Center, The University of Texas, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2010/860160DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864514PMC
September 2010

Vaccine site inflammation potentiates idiotype DNA vaccine-induced therapeutic T cell-, and not B cell-, dependent antilymphoma immunity.

Blood 2009 Nov 11;114(19):4142-9. Epub 2009 Sep 11.

Department of Lymphoma and Myeloma, Center for Cancer Immunology Research, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2009-05-219683DOI Listing
November 2009

Myeloma cell line-derived, pooled heat shock proteins as a universal vaccine for immunotherapy of multiple myeloma.

Blood 2009 Oct 4;114(18):3880-9. Epub 2009 Aug 4.

Department of Lymphoma and Myeloma, Division of Cancer Medicine, and Center for Cancer Immunology Research, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2009-06-22
Publisher Site
http://dx.doi.org/10.1182/blood-2009-06-227355DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2773487PMC
October 2009

Vaccine therapy for B-cell lymphomas: next-generation strategies.

Hematology Am Soc Hematol Educ Program 2007 :243-9

Anderson Cancer Center, 1515 Holcombe Blvd., Unit 429, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2007.1.243DOI Listing
July 2009

IGF-IR tyrosine kinase interacts with NPM-ALK oncogene to induce survival of T-cell ALK+ anaplastic large-cell lymphoma cells.

Blood 2009 Jul 7;114(2):360-70. Epub 2009 May 7.

Department of Hematopathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2007-11-125658DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714211PMC
July 2009

Human-like mouse models for testing the efficacy and safety of anti-beta2-microglobulin monoclonal antibodies to treat myeloma.

Clin Cancer Res 2009 Feb;15(3):951-9

Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-1823DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2659684PMC
February 2009

Efficient modulation of T-cell response by dual-mode, single-carrier delivery of cytokine-targeted siRNA and DNA vaccine to antigen-presenting cells.

Mol Ther 2008 Dec 23;16(12):2011-21. Epub 2008 Sep 23.

Department of Biomedical Engineering, The University of Texas at Austin, Austin, Texas 78712, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S152500161632101
Publisher Site
http://dx.doi.org/10.1038/mt.2008.206DOI Listing
December 2008

Roles of idiotype-specific t cells in myeloma cell growth and survival: Th1 and CTL cells are tumoricidal while Th2 cells promote tumor growth.

Cancer Res 2008 Oct;68(20):8456-64

Department of Lymphoma and Myeloma, Division of Cancer Medicine, Center for Cancer Immunology Research, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2575640PMC
http://dx.doi.org/10.1158/0008-5472.CAN-08-2213DOI Listing
October 2008

A severe combined immunodeficient-hu in vivo mouse model of human primary mantle cell lymphoma.

Clin Cancer Res 2008 Apr;14(7):2154-60

Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-07-4409DOI Listing
April 2008

A novel strategy for rapid and efficient isolation of human tumor-specific CD4(+) and CD8(+) T-cell clones.

J Immunol Methods 2008 Feb 9;331(1-2):13-26. Epub 2007 Oct 9.

Department of Lymphoma and Myeloma, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jim.2007.09.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2265521PMC
February 2008

Survivin DNA vaccine generated specific antitumor effects in pancreatic carcinoma and lymphoma mouse models.

Vaccine 2007 Nov 14;25(46):7955-61. Epub 2007 Sep 14.

Department of Gastrointestinal Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2007.08.050DOI Listing
November 2007

Anti beta2-microglobulin monoclonal antibodies induce apoptosis in myeloma cells by recruiting MHC class I to and excluding growth and survival cytokine receptors from lipid rafts.

Blood 2007 Oct 20;110(8):3028-35. Epub 2007 Jul 20.

Department of Lymphoma and Myeloma, Division of Cancer Medicine, and Center for Cancer Immunology Research, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2007-06-094417DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2018676PMC
October 2007

Dickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myeloma.

Blood 2007 Sep 21;110(5):1587-94. Epub 2007 May 21.

Department of Lymphoma and Myeloma, Division of Cancer Medicine, and the Center for Cancer Immunology Research, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2007-03-082529DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1975842PMC
September 2007

An NKT-mediated autologous vaccine generates CD4 T-cell dependent potent antilymphoma immunity.

Blood 2007 Sep 20;110(6):2013-9. Epub 2007 Jun 20.

Department of Immunology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2006-12-061309DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1976361PMC
September 2007

Human C-reactive protein binds activating Fcgamma receptors and protects myeloma tumor cells from apoptosis.

Cancer Cell 2007 Sep;12(3):252-65

Department of Lymphoma and Myeloma, Division of Cancer Medicine, and the Center for Cancer Immunology Research, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S153561080700235
Publisher Site
http://dx.doi.org/10.1016/j.ccr.2007.08.008DOI Listing
September 2007

A novel proteoliposomal vaccine induces antitumor immunity against follicular lymphoma.

Blood 2007 Jun 5;109(12):5160-3. Epub 2007 Mar 5.

Department of Lymphoma and Myeloma, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2006-12-063594DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1941785PMC
June 2007

Therapeutic vaccine for lymphoma.

Yonsei Med J 2007 Feb;48(1):1-10

Department of Lymphoma and Myeloma, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2628002PMC
http://dx.doi.org/10.3349/ymj.2007.48.1.1DOI Listing
February 2007

Experience with heat shock protein-peptide complex 96 vaccine therapy in patients with indolent non-Hodgkin lymphoma.

Cancer 2007 Jan;109(1):77-83

Department of Lymphoma and Myeloma, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.22389DOI Listing
January 2007

Dose-related safety and immunogenicity of baculovirus-expressed trivalent influenza vaccine: a double-blind, controlled trial in adult patients with non-Hodgkin B cell lymphoma.

J Infect Dis 2006 Nov 6;194(10):1394-7. Epub 2006 Oct 6.

Department of Infectious Diseases, Infection Control, and Employee Health, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/508493DOI Listing
November 2006

Targeting beta2-microglobulin for induction of tumor apoptosis in human hematological malignancies.

Cancer Cell 2006 Oct;10(4):295-307

Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccr.2006.08.025DOI Listing
October 2006

Models for lymphoma.

Curr Protoc Immunol 2002 Feb;Chapter 20:Unit 20.6

National Cancer Institute, Frederick, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/0471142735.im2006s46DOI Listing
February 2002